Table_1_Potential limitations in systematic review studies assessing the effect of the main intervention for treatment/therapy of COVID-19 patients: An overview.pdf

BackgroundAlthough several studies have assessed the safety, efficacy, and effectiveness of interventions in treating the COVID-19, many of them have limitations that can have an immense impact on their results. This study aims to assess the potential limitations in systematic reviews (SRs) that evaluate the effect of interventions on the treatment of the COVID-19.MethodsPubMed, Scopus, and Web of Sciences (WOS) databases were searched from inception to January 1, 2022. All systematic reviews investigated the effectiveness, efficacy, safety, and outcome of the main intervention (Favipiravir, Remdesivir, Hydroxychloroquine, Ivermectin, Lopinavir/Ritonavir, or Tocilizumab) for the treatment of COVID-19 patients and reported the potential limitations of the included studies. We assessed the quality of the included studies using the Quality Assessment Tool (QAT) for review articles. We conducted a content analysis and prepared a narrative summary of the limitations.ResultsForty-six studies were included in this review. Ninety one percent of the included studies scored as strong quality and the remaining (9%) as moderate quality. Only 29.7% of the included systematic reviews have a registered protocol. 26% of the included studies mentioned a funding statement. The main limitations of the included studies were categorized in 10 domains: sample size, heterogeneity, follow-up, treatment, including studies, design, definitions, synthesis, quality, and search.ConclusionVarious limitations have been reported in all the included studies. Indeed, the existence of limitations in studies can affect their results, therefore, identifying these limitations can help researchers design better studies. As a result, stronger studies with more reliable results will be reported and disseminated. Further research on COVID-19 SRs is essential to improve research quality and also, efficiency among scientists across the world.</p

Supplemental Material, sj-doc-1-tva-10.1177_15248380211036060 - Intimate Partner Violence in the Middle East Region: A Systematic Review and Meta-Analysis

Supplemental Material, sj-doc-1-tva-10.1177_15248380211036060 for Intimate Partner Violence in the Middle East Region: A Systematic Review and Meta-Analysis by Mozhgan Moshtagh, Rana Amiri, Simin Sharafi and Morteza Arab-Zozani in Trauma, Violence, & Abuse</p

Additional file 2 of The occurrence, types, reasons, and mitigation strategies of defensive medicine among physicians: a scoping review

Additional file 2

Table_1_Portal Vein Thrombosis Might Develop by COVID-19 Infection or Vaccination: A Systematic Review of Case-Report Studies.DOCX

Background and Objective: Infection by the novel coronavirus disease 2019 (COVID-19) has been associated with different types of thrombotic complications same as portal vein thrombosis (PVT). However, by emerging vaccines of COVID, the thrombosis did not seem to be concerning anymore. Until new findings showed that, the vaccine of COVID itself can cause PVT.Method: We performed an electronic search in PubMed, Scopus, and Web of Sciences to evaluate the possibility of occurring PVT due to infection and vaccination of COVID-19. The results were reported in a narrative method and categorized into tables.Result: Overall, 40 cases of PVT from 34 studies were reviewed in this article. The prevalence of PVT following COVID-19 was more remarkable in males. However, it was more common in females after vaccinations of COVID-19 in the reviewed cases. Regardless of etiology, 20 of PVT cases reviewed in this article had at least one comorbidity. The most common clinical presentation was abdominal pain (AP). After anticoagulant therapies, most of the patients improved or discharged.Conclusion: As long as the laboratory findings are not appropriate enough to predict PVT, the diagnosis of this complication with whatever underlying reason is challengeable, while rapid diagnosis and treatment of that are vital. Therefore, by providing available data in an organized way, we aimed to prepare the information of infected patients for better and easier future diagnosis of PVT in new cases.</p

Additional file 1 of The occurrence, types, reasons, and mitigation strategies of defensive medicine among physicians: a scoping review

Additional file 1: Supplementary file 1. Full list of Search strategy in Three Databases

Assessment of the properties of the EQ-5D-5L in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

This study systematically reviews the validity, reliability, and responsiveness of the EQ-5D-5 L in studies of T2DM. Relevant articles were retrieved by searching four databases, namely, the Web of Science, Scopus, PubMed, and Cochrane Library up to November 2020 with English language. All stages of the review conducted by two authors and disagreements were solved by consultation with a third reviewer. Of the 1614 identified studies, 46 were remained for review. The EQ-5D-5 L mean scores ranged from 0.314 (0.4) (n = 141) for diabetic patients undergoing hemodialysis to 0.971 (0.082) (n = 56) for diabetic patient without retinopathy. Mean EQ-5D-5 L scores in men (0.847) were higher those in women (0.747). Construct validity and reliability was confirmed in the studies that reported the properties of the EQ-5D-5 L, and responsiveness reported in a study that was good. There were ceiling effects in seven studies. The overall utility value was higher in Japan (0.86, 95% CI: 0.80–0.92, p = 0.0001) thanCanada (0.79, 95% CI: 0.78–0.80, p = 0.81), and the United Kingdom (0.72, 95% CI: 0.64–0.79, p = 0.0001). Findings demonstrated validity, reliability of the EQ-5D-5 L in T2DM and the existence of ceiling effects. However, the assessment of responsiveness and sensitivity needs further observations.</p

sj-docx-1-smo-10.1177_20503121221118712 – Supplemental material for Prevalence of physical activity using validated tools among adults during the COVID-19 pandemic in the Eastern Mediterranean region: A systematic review and meta-analysis

Supplemental material, sj-docx-1-smo-10.1177_20503121221118712 for Prevalence of physical activity using validated tools among adults during the COVID-19 pandemic in the Eastern Mediterranean region: A systematic review and meta-analysis by Ahmed Hassan Albelbeisi, Morteza Arab-Zozani, Marjan Khabiri Nemati, Khalil Mostafa Shaqfa and Edris Kakemam in SAGE Open Medicine</p

Additional file 1: of Prevalence of medical errors in Iran: a systematic review and meta-analysis

Search strategy in databases. (DOCX 13 kb

Additional file 3: of Prevalence of medical errors in Iran: a systematic review and meta-analysis

Detailed summary of the outcome measures and results of included studies. (DOCX 43 kb

Additional file 2: of Prevalence of medical errors in Iran: a systematic review and meta-analysis

Critical appraisal results of the included studies. (DOCX 42 kb